Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices

Report on Business

Streetwise

News and analysis on Bay Street and the world of finance
available exclusively to subscribers of Globe Unlimited

Entry archive:

Signs point to health-care M&A revival Add to ...

Subscribers Only

Valeant Pharmaceuticals International Inc.’s $8.7-billion (U.S.) bid for eye-care company Bausch & Lomb Inc. on Monday wasn’t just the largest purchase ever made by the deal-hungry company, it also made the list of top-ten mergers and acquisitions announced around the world this year.

And it’s not alone. Health-care targets now make up four of the top ten spots in the global ranking of M&A, according to Thomson Reuters numbers pulled on May 28 -- deals worth nearly $46-billion.

Report Typo/Error

Follow on Twitter: @j2nelson

Next story

loading

Trending

loading

Most popular videos »

More from The Globe and Mail

Most popular